Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Summary

Subjects must be 18- 75 years old and have a history of both inflammatory bowels disease (Crohn's or ulcerative colitis) and pyoderma gangrenosum. This is a 6 month open label study of an intravenous (IV) medication. Visits occur every 2 weeks initially, then every 1-2 months later in the study.

Timeline

Start

2008-10

Primary completion

2009-12

Completion

2010-02

Drugs

Indications